FocusInfectious Disease

Neutralizing the MERS Coronavirus Threat

See allHide authors and affiliations

Science Translational Medicine  07 May 2014:
Vol. 6, Issue 235, pp. 235fs19
DOI: 10.1126/scitranslmed.3009132

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Human neutralizing monoclonal antibodies are candidates for prophylactic and therapeutic interventions against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.

View Full Text